CS70091A2 - Method of aspartame production - Google Patents

Method of aspartame production Download PDF

Info

Publication number
CS70091A2
CS70091A2 CS91700A CS70091A CS70091A2 CS 70091 A2 CS70091 A2 CS 70091A2 CS 91700 A CS91700 A CS 91700A CS 70091 A CS70091 A CS 70091A CS 70091 A2 CS70091 A2 CS 70091A2
Authority
CS
Czechoslovakia
Prior art keywords
dioxopiperazine
acetate
alkyl
acyl
compound
Prior art date
Application number
CS91700A
Other languages
Czech (cs)
English (en)
Inventor
John B Hill
Mark R Johnson
Tse-Lok Ho
Russel Klix
Original Assignee
Nutrasweet Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrasweet Co filed Critical Nutrasweet Co
Publication of CS70091A2 publication Critical patent/CS70091A2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • C07K5/06113Asp- or Asn-amino acid
    • C07K5/06121Asp- or Asn-amino acid the second amino acid being aromatic or cycloaliphatic
    • C07K5/0613Aspartame
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS91700A 1990-03-15 1991-03-15 Method of aspartame production CS70091A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49824390A 1990-03-15 1990-03-15
US60665690A 1990-10-31 1990-10-31
US65878491A 1991-02-26 1991-02-26
US66480691A 1991-03-08 1991-03-08

Publications (1)

Publication Number Publication Date
CS70091A2 true CS70091A2 (en) 1991-10-15

Family

ID=27504394

Family Applications (1)

Application Number Title Priority Date Filing Date
CS91700A CS70091A2 (en) 1990-03-15 1991-03-15 Method of aspartame production

Country Status (16)

Country Link
EP (1) EP0478729B1 (no)
CN (1) CN1057835A (no)
AT (1) ATE141613T1 (no)
AU (1) AU628257B2 (no)
CA (1) CA2060515A1 (no)
CS (1) CS70091A2 (no)
DE (1) DE69121502T2 (no)
DK (1) DK0478729T3 (no)
ES (1) ES2091324T3 (no)
GR (1) GR3020839T3 (no)
HU (1) HUT60712A (no)
IE (1) IE910896A1 (no)
NO (1) NO920193D0 (no)
NZ (1) NZ237469A (no)
PT (1) PT97049B (no)
WO (1) WO1991014378A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04234374A (ja) * 1990-12-27 1992-08-24 Ajinomoto Co Inc ジケトピペラジン誘導体の製造方法
JPH04234375A (ja) * 1990-12-27 1992-08-24 Ajinomoto Co Inc 新規2,5−ジオキソピペラジン化合物及びその製造法
JPH05117246A (ja) * 1991-10-23 1993-05-14 Ajinomoto Co Inc 新規2,5−ジオキソピペラジン化合物とその製造法及びα−L−アスパルチル−L−フエニルアラニンメチルエステル誘導体の製造法
US6465677B1 (en) 1998-11-19 2002-10-15 The Nutrasweet Company Method for the preparation of N-neohexyl-α-aspartyl-L-phenylalanine methyl ester from imidazolidin-4-one intermediates
DE10019879A1 (de) * 2000-04-20 2001-10-25 Degussa Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung
JP5048201B2 (ja) 2000-08-04 2012-10-17 ディーエムアイ バイオサイエンシズ インコーポレイテッド ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物
GB2382346B (en) * 2000-08-04 2004-08-11 Dmi Biosciences Inc Method of synthesizing diketopiperazines
EP2517721A3 (en) 2003-05-15 2013-04-10 DMI Biosciences, Inc. Treatment of T-cell mediated diseases
US8217047B2 (en) 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
EP2613786A4 (en) 2010-09-07 2013-10-23 Dmi Acquisition Corp TREATMENT OF DISEASES
EP3721884A1 (en) 2011-10-10 2020-10-14 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease with da-dkp (= aspartyl-alanyl diketopiperazine)
MX2014003856A (es) 2011-10-10 2015-01-16 Ampio Pharmaceuticals Inc Dispositivos medicos implantables con tolerancia inmune incrementada y metodos para hacerlos e implantarlos.
EP2771007B1 (en) 2011-10-28 2018-04-04 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
US9808454B2 (en) 2013-03-15 2017-11-07 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
KR20170045274A (ko) 2014-08-18 2017-04-26 앰피오 파마슈티컬스 인코퍼레이티드 관절 징후의 치료
WO2016209969A1 (en) 2015-06-22 2016-12-29 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
KR20190095420A (ko) * 2016-12-21 2019-08-14 산토리 홀딩스 가부시키가이샤 시클로아스파르틸글리신, 글루코오스, 및 말토오스를 함유하는 음식품

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2038106A1 (de) * 1970-07-31 1972-02-10 Henkel & Cie Gmbh Aktivatoren fuer Perverbindungen
JPS58185545A (ja) * 1982-04-22 1983-10-29 Ajinomoto Co Inc α−L−アスパルチル−L−フエニルアラニンメチルエステルまたはその塩酸塩の製法
IT1197461B (it) * 1983-05-13 1988-11-30 Debi Derivati Biologici Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenil-alanina
JPS60174799A (ja) * 1984-02-21 1985-09-09 Ajinomoto Co Inc α−L−アスパルチル−L−フエニルアラニンメチルエステルの製造法
AU586669B2 (en) * 1985-03-29 1989-07-20 Mitsui Toatsu Chemicals Inc. Preparation process of ```-L-aspartyl-L-phenylalanine methyl ester or hydrochloride thereof
JPH0647600B2 (ja) * 1985-06-04 1994-06-22 味の素株式会社 β−アスパルチルフエニルアラニン誘導体のα−アスパルチルフエニルアラニン誘導体への変換法
US4677220A (en) * 1985-10-31 1987-06-30 Monsanto Company Process for the preparation of α-L-aspartyl-L-phenylalanine methyl ester
DE3600731A1 (de) * 1986-01-13 1987-07-16 Green Cross Korea Verfahren zur herstellung von (alpha)-l-aspartyl-l-phenylalaninmethylester
US4992552A (en) * 1988-08-31 1991-02-12 Eastman Kodak Company Process for preparation of amino acids

Also Published As

Publication number Publication date
GR3020839T3 (en) 1996-11-30
AU7564891A (en) 1991-10-21
NO920193L (no) 1992-01-15
EP0478729B1 (en) 1996-08-21
DK0478729T3 (da) 1996-09-16
IE910896A1 (en) 1991-09-25
ES2091324T3 (es) 1996-11-01
DE69121502T2 (de) 1997-01-16
NO920193D0 (no) 1992-01-15
CN1057835A (zh) 1992-01-15
EP0478729A1 (en) 1992-04-08
NZ237469A (en) 1993-08-26
AU628257B2 (en) 1992-09-10
CA2060515A1 (en) 1991-09-16
PT97049A (pt) 1991-12-31
PT97049B (pt) 1998-07-31
EP0478729A4 (en) 1993-06-16
ATE141613T1 (de) 1996-09-15
DE69121502D1 (de) 1996-09-26
HUT60712A (en) 1992-10-28
WO1991014378A1 (en) 1991-10-03

Similar Documents

Publication Publication Date Title
CS70091A2 (en) Method of aspartame production
KR910000234B1 (ko) 시스, 엔도-2-아자비사이클로[5.3.0]데칸-3-카복실산 유도체의 제조방법
FR2606018A1 (fr) Nouveaux a-aminoacides substitues, leur preparation et leur utilisation en therapeutique comme medicaments
HU190486B (en) Process for producing spiro /4./3+n// -2-azaalkane-3-carboxylic acid-derivatives and pharmaceutical compositions containing the same
JP2003171365A (ja) モナティン類及びその製造中間体の製造方法並びに新規中間体
HUP0202437A2 (hu) Új eljárás (2S,3aS,7aS)-1-[(S)-alanil]oktahidro-1H-indol-2-karbonsav vegyületek előállítására és ezek alkalmazása perindopril előállítására
HRP20040935A2 (en) Method for preparing combretastatins
EP1603558B1 (en) Process for preparation of perindopril and salts thereof
JP3247696B2 (ja) 〔1s−(1r*,2s*,3r*)〕−n−(4−モルホリニルスルホニル)−l−フェニルアラニル−3−(2−アミノ−4−チアゾリル)−n−〔(1−シクロヘキシルメチル)−2,3−ジヒドロキシ−5−メチルヘキシル〕−l−アラニンアミドの改良された製法
HU191120B (en) Process for raceme separation of optically active byciclic imino-alpha-carbonic acid esthers
US5420283A (en) Resolution of (R)-2-benzylsuccinic acid 4-[4-(N-t-butoxycarbonylmethylamino)-piperidine] amide
KR100563894B1 (ko) 가바펜틴 동족체의 신규 입체선택적 제조 방법
US6759555B2 (en) Process for the preparation of combretastatins
IE47073B1 (en) Alpha amino-acids, compositions and process for preparing said compounds
JPH02256655A (ja) 光学活性なスレオージヒドロキシフェニルセリン誘導体の製造方法
JPH06184069A (ja) α−ヒドロキシ−β−アミノカルボン酸の製造方法
EP1724260B1 (en) Process for the synthesis of (2S, 3aR, 7aS)octahydroindole-2-carboxylic acid and its conversion to trandolapril
JP2730135B2 (ja) 酸アミド誘導体
Shin et al. Dehydrooligopeptides. VIII. Convenient syntheses of various dehydrotyrosine derivatives protected with useful N, O-protecting groups via N-carboxy dehydrotyrosine anhydrides.
NO172940B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bisykliske aminosyrer
WO2007085933A2 (en) Process for the preparation of n-[1-(s)-ethoxycarbonyl-1-butyl]-(s)-alanine-dmt complex and its use in the preparation of perindopril
CA1275348C (en) Method and intermediates for producing -l-aspartyl- l-phenylalanine
JPH06340623A (ja) ベンジルコハク酸誘導体の製造方法およびその製造中間体
EP1513868A1 (en) Process for the production of lisinopril
NO176763B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive azepinonderivater